Dr Fiona Blackhall is a Professor of Thoracic Oncology within the Institute of Cancer Studies, University of Manchester, UK, and a Consultant Medical Oncologist at The Christie Hospital, Manchester, UK.
She has specific research interests in targeted therapies, personalized medicine, circulating biomarkers and small-cell lung cancer, and conducts clinical trials of new drugs for the treatment of lung cancer and translational research in clinically relevant biomarkers.
She has served as co-chair of the translational subgroup of the European Thoracic Oncology Platform and on the scientific committee and the ESMO consensus guidelines panel for lung cancer for ESMO. She has been a faculty member and invited speaker for the ASCO Annual Meeting and IASLC.